![]() have genetic mutation of the SCN1A gene must be documented.have brain MRI without cortical malformation, and.have a history of seizures that are generalized, unilateral clonic, and/or hemiclonic,.controlled with current treatmenthave onset of seizures prior to 18 months of age,. ![]() have been diagnosed with Dravet syndrome seizures are not completely.You may be eligible to participate in the Argus Trial if you: This single pivotal study named Argus trial: Argus trial is a 20-week multicenter, randomized, double-blind, placebo-controlled trial of EPX-100 as adjunctive therapy in patients with Dravet syndrome. is actively recruiting patients with Dravet syndrome.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |